Skip to content
Open access · CC-BY via OpenAlex

Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging

Song-Yi Han, Mukesh Kumar Yadav, Jing‐Hua Wang

Biomedicines · 2026 · ▲ 3 citations

Abstract

Metformin is a first-line oral antidiabetic agent that has attracted increasing interest as a potential geroprotective therapy due to its ability to improve metabolic homeostasis, reduce oxidative stress, and attenuate chronic inflammation. However, its role in skeletal muscle aging and sarcopenia remains controversial. Observational and epidemiological studies suggest that metformin use is associated with a lower prevalence of sarcopenia, particularly in metabolically compromised or insulin-resistant older populations, where improvements in systemic metabolism and inflammatory burden may indirectly support muscle quality and function. In contrast, randomized interventional trials in metabolically healthy older adults indicate that metformin can blunt resistance exercise-induced muscle hypertrophy and protein synthesis, likely through sustained activation of AMP-activated protein kinase (AMPK) and consequent suppression of mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) complex 1 (mTORC1) signaling. This perspective argues that these apparently opposing outcomes reflect a con-text-dependent therapeutic paradox rather than inconsistent evidence. Metformin may provide metabolic protection in frail, insulin-resistant individuals, yet limit anabolic adaptations in physically active older adults. These findings emphasize the necessity for precision geropharmacological strategies to balance metabolic longevity with preservation of musculoskeletal health in aging populations.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/biomedicines14020376
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Han, S., Yadav, M.K., &amp; Wang, J. (2026). Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging. <em>Biomedicines</em>. https://doi.org/10.3390/biomedicines14020376
Vancouver
Han S, Yadav MK, Wang J. Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging. Biomedicines. 2026. doi:10.3390/biomedicines14020376.
BibTeX
@article{songyi2026Metfor, title = {Metformin for Longevity and Sarcopenia: A Therapeutic Paradox in Aging}, author = {Song-Yi Han and Mukesh Kumar Yadav and Jing‐Hua Wang}, journal = {Biomedicines}, year = {2026}, doi = {10.3390/biomedicines14020376}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings